Sonofii, Inc. is an early stage life science company founded to improve healing of soft tissue infections and chronic wounds.
Our proprietary, patent-protected technology has resolved previously difficult to treat infections and accelerated wound healing in a clinical trial.
Sonofii’s procedure is easy to learn and integrates well with current care.
Physicians benefit from providing better care to their patients
Patients benefit from faster healing and faster return to normal activity.
Hospitals benefit
from faster recovery
and decreased
length of stay.
The healthcare system benefits from a significant reduction in cost of care.
Sonofii’s technology is investigational and not approved by the FDA for commercial use.
If you would like to learn more or would like to join us in
our path towards FDA approval please contact us.